← Zurück zum Screener

Lumibird

LBIRD.PA Small Cap

Healthcare · Diagnostics & Research

Aktualisiert: Apr 5, 2026, 17:43 UTC

€21.70
-0.46% heute
52W: €8.14 – €24.50
52W Low: €8.14 Position: 82.9% 52W High: €24.50

Kennzahlen

P/E Ratio
45.21x
Kurs/Gewinn-Verhältnis
Forward P/E
17.36x
Erwartetes KGV
P/S Ratio
2.12x
Kurs/Umsatz-Verhältnis
EV/EBITDA
Unternehmenswert/EBITDA
Dividendenrendite
Jährl. Dividendenrendite
Market Cap
$477.9M
Marktkapitalisierung
Umsatzwachstum
5.9%
YoY Umsatzwachstum
Gewinnmarge
6.21%
Nettomarge
ROE
6.93%
Eigenkapitalrendite
Beta
0.87
Marktsensitivität
Short Interest
% der Aktien leerverkauft
Ø Volumen
32,051
Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal
Überbewertet
vs. S&P 500 Ø KGV (24.7x)
Analysten-Konsens
None
2 Analysten
Ø Kursziel
€28.40
+30.88% Upside
Kursziel Spanne
€28.30 – €28.50

Über das Unternehmen

Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications. It operates in two divisions, Photonics and Medical. The company offers solid-state lasers, laser diodes and components, fiber lasers and amplifiers, and high-power fiber lasers; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military lasers rangefinders, and medical and ophthalmological solutions. Its products are used in various applications, such as defense and space, environment, topography and safety, industry and science, and science and healthcare industries. The company was incorporated in 1970 and is headquartered in Lannion, France. Lumibird SA is a subsidiary of ESIRA.

Sektor: Healthcare Branche: Diagnostics & Research Land: France Börse: PAR

Trading-Daten

50-Day MA: €22.48
200-Day MA: €20.47
Volumen: 26,922
Ø Volumen: 32,051
Short Ratio:
Kurs/Buchwert: 2.44x
Verschuldung/EK: 70.87x
Free Cash Flow: $-13,643,000

Wo kann ich Lumibird kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Nach oben scrollen